238 related articles for article (PubMed ID: 35092368)
21. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
[TBL] [Abstract][Full Text] [Related]
22. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
25. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
26. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
28. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
Kassirian S; Hinton SN; Cuninghame S; Chaudhary R; Iansavitchene A; Amjadi K; Dhaliwal I; Zeman-Pocrnich C; Mitchell MA
Thorax; 2023 Jan; 78(1):32-40. PubMed ID: 35110369
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
30. Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.
Liu C; Huang L; Zhang X; Yang J
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):376-381. PubMed ID: 29069463
[TBL] [Abstract][Full Text] [Related]
31. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
[TBL] [Abstract][Full Text] [Related]
32. Pleural homocysteine for malignant pleural effusion: A prospective and double-blind diagnostic test accuracy study.
Cao XS; Zhao W; Wen XH; Han YL; Yan L; Jiang TW; Huang JH; Chen H; Zheng WQ; Hu ZD
Thorac Cancer; 2022 Aug; 13(16):2355-2361. PubMed ID: 35817406
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.
Wang S; Tian S; Li Y; Zhan N; Guo Y; Liu Y; Xu J; Ma Y; Zhang S; Song S; Geng W; Xia H; Ma P; Wang X; Liao T; Duan Y; Jin Y; Dong W
EBioMedicine; 2020 Aug; 58():102924. PubMed ID: 32739872
[TBL] [Abstract][Full Text] [Related]
36. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
37. mRNA markers associated with malignant pleural effusion.
Hsu SC; Chang SY; Hwang YT; Terng HJ; Tsai CL; Shen CH; Huang SK; Chian CF
Sci Rep; 2023 Apr; 13(1):6677. PubMed ID: 37095178
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pleural fluid cytology for the diagnosis of malignant pleural effusion: a retrospective cohort study.
Pairman L; Beckert LEL; Dagger M; Maze MJ
Intern Med J; 2022 Jul; 52(7):1154-1159. PubMed ID: 35191191
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
40. Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.
Wang K; Hu X; Chen Y; Yi X; Han X; Zhu D; Zhu B; Luo H
Clin Respir J; 2024 Jan; 18(1):e13705. PubMed ID: 37775991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]